ShathaYounis MustafaFarhanMDAssistant Professor

Hematology • Detroit, MI

Hematologic Oncology

Stem cell transplant & cellular therapy

Join to view full profile

Dr. Farhan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Farhan's full profile

Already have an account?

Office
2799 W Grand Blvd
Detroit, MI 48202
Phone+1 313-916-9100

Education & Training

Henry Ford Health/Henry Ford HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2005 - 2008
University of Jordan Faculty of MedicineClass of 2003
University of Texas M D Anderson Cancer CenterFellowship, Blood & Bone Marrow Transplant

Certifications & Licensure

MI State Medical License 2005 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib Start of enrollment: 2016 Mar 08
Recruiting
Phase 2
Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant Start of enrollment: 2018 Mar 14
Active, not recruiting
Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant Start of enrollment: 2019 Jul 01
Recruiting
Phase 2

Publications & Presentations

PubMed

2 citations
CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.
Priyanka A Pophali, Joshua A Fein, Kwang W Ahn, Molly Allbee-Johnson, Nausheen Ahmed
Blood Advances. 2024-10-22
1 citations
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.
Tania Jain, Noel Estrada-Merly, M Queralt Salas, Soyoung Kim, Jakob DeVos
Blood Advances. 2024-08-27
2 citations
Graft-versus-host disease: teaching old drugs new tricks at less cost.
Shatha Farhan, Shernan G Holtan
Frontiers in Immunology. 2023-01-01

Journal Articles

Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Periphe...
shatha farhan, Adv Hematology